Search Results

pathways” to understanding localized signaling architecture — is what drove her to build a research career

am a postdoctoral research fellow endeavoring to build a productive, independent scientific research career

Join me and learn more about Debbie’s career and what she learned through her experiences as a scientist

How Michelle Halls turned an unexpected summer project into a GPCR research career redefining spatial

Home → Flash News → 🎯 Crack the code of GPCR ligand development! In case you haven’t heard, Dr. Terry Kenakin is hosting a 4-week course on GPCR drug development—and registration closes in 3 days! 👉 Development of GPCR Ligands as Therapeutic Drugs | Dr. GPCR Courses 🎯 Crack the code of GPCR ligand development! In case you haven’t heard, Dr. 👉 Development of GPCR Ligands as Therapeutic Drugs | Dr.

Home → Flash News → 🚨 Exciting Opportunity for Professionals in Drug Development! GPCR University: "Development of GPCR Ligands as Therapeutic Drugs." 🗓 Dates: March 20 - April 10, 2025 : Thursdays, 10:00 AM - 11:30 AM (EST) This advanced course is essential for anyone working in drug development GPCR Courses 🚨 Exciting Opportunity for Professionals in Drug Development! GPCR University: "Development of GPCR Ligands as Therapeutic Drugs." 🗓 Dates: March 20 - April 10, 2025

Home → Flash News → 💡 GPCR drug development doesn’t have to be a mystery! Learn from Dr. Terry Kenakin in this 4-week immersive course covering ligand development & pharmacology. 🔹 What you Sign up today 👉 Development of GPCR Ligands as Therapeutic Drugs | Dr. GPCR Courses 💡 GPCR drug development doesn’t have to be a mystery! Learn from Dr. Sign up today 👉 Development of GPCR Ligands as Therapeutic Drugs | Dr.

Home → Flash News → In case you haven’t heard, registrations are open for the next 4-week course “Development with your Premium Membership 🚀 ✳️Go to https://www.ecosystem.drgpcr.com/event-details-registration/development-of-gpcr-ligands-as-therapeutic-drugs GPCR Courses In case you haven’t heard, registrations are open for the next 4-week course “Development with your Premium Membership 🚀 ✳️Go to https://www.ecosystem.drgpcr.com/event-details-registration/development-of-gpcr-ligands-as-therapeutic-drugs

Terry Kenakin, “Development of GPCR Ligands as Therapeutic Drugs” is coming up 🧐 Be the first to register ✳️Go to https://www.ecosystem.drgpcr.com/event-details-registration/development-of-gpcr-ligands-as-therapeutic-drugs Terry Kenakin, “Development of GPCR Ligands as Therapeutic Drugs” is coming up 🧐 Be the first to register ✳️Go to https://www.ecosystem.drgpcr.com/event-details-registration/development-of-gpcr-ligands-as-therapeutic-drugs

“Development of GPCR Ligands as Therapeutic Drugs” with Dr. Terry Kenakin is here! 👉 https://www.ecosystem.drgpcr.com/event-details-registration/development-of-gpcr-ligands-as-therapeutic-drugs “Development of GPCR Ligands as Therapeutic Drugs” with Dr. Terry Kenakin is here! 👉 https://www.ecosystem.drgpcr.com/event-details-registration/development-of-gpcr-ligands-as-therapeutic-drugs

In our AMA, Terry Kenakin shared timeless career advice for young pharmacologists navigating a fast-changing

Home → Flash News → ⏳ In case you haven’t heard—registration for “Development of GPCR Ligands as Therapeutic 👉 Development of GPCR Ligands as Therapeutic Drugs | Dr. GPCR Courses ⏳ In case you haven’t heard—registration for “Development of GPCR Ligands as Therapeutic 👉 Development of GPCR Ligands as Therapeutic Drugs | Dr.

Explore the fascinating career journeys, groundbreaking discoveries, and impactful contributions of experts We discuss breakthrough discoveries, career paths in pharmacology and molecular biology, and how each We aim to have engaging conversations about you as a scientist, your career, your work, and anything We'll then engage in a conversation centered around your career and how you got introduced to GPCRs.

All through her career, the recurring theme in Kari’s work has been GPCRs and more specifically Metabotropic

Check out the development of a NanoBRET assay platform to detect intracellular ligands for the chemokine Check out the development of a NanoBRET assay platform to detect intracellular ligands for the chemokine ➡️ https://www.ecosystem.drgpcr.com/methods-and-updates-in-gpcr-research/development-of-a-nanobret-assay-platform-to-detect-intracellular-ligands-for-the-chemokine-receptors-ccr6

Catherine, a PhD candidate at the University of Michigan, shares how personal loss and an unconventional career discovery scientists Respiratory pharmacologists Addiction researchers Public health professionals Early-career

Although both went to the same college, Jacob and Jin choose different career paths.

Join me and learn more about Annette’s career, our common love for chemokines, and how you can use your

In his (future) independent research career, Aditya aims to work at the interface of GPCR molecular pharmacology

🌟 Researchers have developed reversibly photoswitchable allosteric modulators for Class A GPCRs! 🌟 Researchers have developed reversibly photoswitchable allosteric modulators for Class A GPCRs!

✳️Celtarys is ready to support your assay development. Get to know more: Celtarys Research | Dr. ✳️Celtarys is ready to support your assay development. Get to know more: Celtarys Research | Dr.

GPCR to support assay development worldwide. GPCR to support assay development worldwide.

🚀 Dr.GPCR x Celtarys are teaming up to revolutionize fluorescent ligand development for GPCR research 🚀 Dr.GPCR x Celtarys are teaming up to revolutionize fluorescent ligand development for GPCR research

Tom Sakmar and Ilana Kotliar about how their lab developed: A multiplexed Luminex assay to screen hundreds Tom Sakmar and Ilana Kotliar about how their lab developed: A multiplexed Luminex assay to screen hundreds

scientific publications, he is most beloved as a mentor and his relentless encouragement that shaped the careers

scientific publications, he is most beloved as a mentor and his relentless encouragement that shaped the careers

scientific publications, he is most beloved as a mentor and his relentless encouragement that shaped the careers

In 2013, Demet began her independent research career at the University of Chicago within the Department receptor activator and continuously work to identify novel chemical modulators of AGPCRs through assay development I have previous work experience at two separate contract research organizations centered on assay development

His thesis work led to the development and application of light energy transfer methodology to study His research program is developed to understand the signaling mechanisms underlying the Wnt and Hedgehog families of growth factors and their signaling mechanisms in development, adult tissue homeostasis, His pioneer work led to the development of novel antibody molecules blocking and activating the Wnt pathway biotech companies, ModMab Therapeutics , and AntlerA Therapeutics , which are pursuing the clinical development

Discover how Celtarys Research is transforming GPCR assay development with fluorescent ligands in this At Celtarys, the focus is on enabling fast, customizable development of fluorescent ligands and chemical Their approach is highly consultative—they don’t just sell ligands, they co-develop solutions. Whether you're designing assays, developing probes, or seeking better tools for GPCR drug discovery, , GPCR assay development , G protein-coupled receptors , GPCR podcast , Celtarys partnership Summary